Article
Brochure
Executive Resource
Insight Hub
Video
Ext. Publication
Home /
Insights & Resources
Insights & Resources
Start exploring insights from across the industries we serve, featuring the latest industry trends, compliance alerts, tax and accounting news and much more.
- Alternative Investments
- Banking
- Blockchain & Digital Assets
- Construction
- Consumer Products
- Energy Transition
- Financial Services
- Food & Beverage
- General Business
- Government
- Health Care
- Higher Education
- Hospitality & Entertainment
- Industrial Products
- Insurance
- Life Sciences
- Not-for-Profit
- Oil & Gas
- Oilfield Services
- Real Estate
- Renewable Fuels
- Technology
- Transportation & Logistics
- Accounting Advisory
- Artificial Intelligence
- Asset Management Consulting
- Asset Tracing
- Cybersecurity
- Data Privacy
- Digital Transformation
- Energy Compliance
- Executive & Leadership Coaching
- Family Law
- Forensics & Litigation
- Government Consulting
- Health Care Valuation
- IT Advisory
- Risk Advisory
- Sustainability Consulting
- Transaction Advisory
- Trust & Estate
- Valuation
Costs are climbing across health care supply chains. Learn which areas face the most pressure and how to plan with confidence.
Forensic accountants value businesses and partnerships in divorce, separating personal from enterprise goodwill to support equitable outcomes.
Forensic accountants trace funds in divorce, clarifying commingling and financial history to support equitable outcomes.
Divorce cases demand financial transparency. Forensic accountants uncover hidden assets and provide evidence that holds up in court.
The Lloyd v. Argent Trust Co. ruling shows why valuation integrity and asset tracing can be pivotal in fiduciary breach and ERISA litigation cases.
As risk evolves, life science companies must adapt valuation methods. Learn to better align risk, value and strategy in your decision-making process.
FY 2026 ACA enrollment growth may impact health care valuations. Learn how the shift may shape provider revenue and risk.
J.P. Morgan's Q1 2025 biopharma and medtech reports reveal larger deals, global growth and financial strategies shaping the life sciences industry.
See how ambulatory surgery centers (ASC) and imaging center valuation multiples compare, revealing key differences, patterns and transaction risk.
Explore why profitable hospitals command higher valuations and how variability in transaction databases impacts fair market value.
Explore how proposed Medicaid cuts could impact health care valuations, reimbursement models and financial stability across various provider segments.
Learn about the risks of profit tunneling in nursing homes and why fair market value transactions help ensure compliance and financial integrity.
